Last updated at 08 Mar 2024 12:00 PM
Director
DIN: 00043314
Kandasamy Subramanian Mahadevan is currently associated with 2 companies in various capacities such as Director and Partner. They serve as a Director at ERODE PHARMA PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 00043314.Kandasamy Subramanian Mahadevan has previously been associated with 2 companies in roles such as Director, Managing Director and Additional Director.Kandasamy Subramanian Mahadevan is currently involved in 2 different roles. Their most recent position is with NANBARGAL PHARMA LLP as a Partner. The first company Kandasamy Subramanian Mahadevan was appointed to as a director was ERODE PHARMA PRIVATE LIMITED. Kandasamy Subramanian Mahadevan has a status of Deactivated. Please verify the details for any specific requirements or conditions.
Kandasamy Subramanian Mahadevan is currently associated with 2 companies in various capacities such as Director and Partner. They serve as a Director at ERODE PHARMA PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 00043314.Kandasamy Subramanian Mahadevan has previously been associated with 2 companies in roles such as Director, Managing Director and Additional Director.Kandasamy Subramanian Mahadevan is currently involved in 2 different roles. Their most recent position is with NANBARGAL PHARMA LLP as a Partner. The first company Kandasamy Subramanian Mahadevan was appointed to as a director was ERODE PHARMA PRIVATE LIMITED. Kandasamy Subramanian Mahadevan has a status of Deactivated. Please verify the details for any specific requirements or conditions.
2
Male
India
Gain instant access to verified contact details.
Current Companies (1)
Current LLPs (1)
Past Companies (2)
6y 1m 3y 1m Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| ERODE PHARMA PRIVATE LIMITED | Director | 01-Feb-2010 |